Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
6.24
-0.41 (-6.17%)
At close: Jul 25, 2025, 4:00 PM
6.30
+0.06 (0.96%)
After-hours: Jul 25, 2025, 7:31 PM EDT
Champions Oncology Revenue
In the fiscal year ending April 30, 2025, Champions Oncology had annual revenue of $56.94M with 13.54% growth. Champions Oncology had revenue of $12.36M in the quarter ending April 30, 2025, a decrease of -11.76%.
Revenue (ttm)
$56.94M
Revenue Growth
+13.54%
P/S Ratio
1.50
Revenue / Employee
$267,343
Employees
213
Market Cap
85.83M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CSBR News
- 13 hours ago - Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Champions Oncology Reports Record Annual Revenue of $57 Million - Accesswire
- 4 days ago - Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025 - Accesswire
- 7 days ago - Champions Oncology Announces Appointment of New CEO - Accesswire
- 17 days ago - Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models - Accesswire
- 5 weeks ago - Champions Oncology: Biological IP Is The Real Asset - Not Preclinical Services - Seeking Alpha
- 3 months ago - Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House - Accesswire
- 3 months ago - Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine - Accesswire